Search

everythinglearnresearchcommunity

for

Search:↓

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Balancing testosterone may reduce COVID-19 severity.

Engineered vesicles deliver mitochondria to improve diabetic wound healing.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Sarcoptes scabiei infection causes significant health and behavior changes in wombats.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Scientists successfully created and transplanted bioengineered hair follicles that function like natural ones, suggesting a new treatment for hair loss.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Leprosy is mainly contracted during infancy or childhood.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

The symposium concluded that environmental factors significantly contribute to skin aging.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Entospletinib effectively prevents eye and skin GVHD in mice.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Lymphocytes may hinder hair stem cells, causing hair loss without scarring.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Skin and mucous membrane issues are common in kids after bone marrow transplants, so careful monitoring is crucial.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.